CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Public Equity (NYSE)BiotechnologyDrug DiscoveryHealthcare

📍 Wilmington, MA, United States• 19000 employees

StreetZero Signal 67

Be the first to signal interest

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Charles River Laboratories International, Inc., based in Wilmington, Massachusetts, is a leading provider of critical research tools and integrated support services that enable innovative and efficient drug discovery and development. Charles River is the global leader in providing the animal research models required in research and development for new drugs, devices and therapies and has been in this business for more than 50 years. Since 1992, the Company has built upon its research model technologies to develop a broad and growing portfolio of biomedical products and services. The Company offers a wide array of services that enable its customers to reduce costs.

LATEST FUNDINGRule 144

$8.4M

Announced 2026-10-22

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES19000

FOUNDED—

HQWilmington, MA, United States

Industry

Public Equity (NYSE)

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Completed $224M initial public offering of common stock.
Lead investor DLJ Merchant Banking Group distributed millions of shares to limited partners in 2001-2002.
Employs approximately 19,000 people and operates in the US, Europe, Canada and Asia Pacific.
Provides research models, non-clinical development and safety testing services globally.

Ask StreetZero about CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Put our AI to work on this deal.

What is CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s value proposition?Who are CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s competitors?Why does this raise matter?Summarize CHARLES RIVER LABORATORIES INTERNATIONAL, INC. for an investor.

Similar companies

Other Public Equity (NYSE) deals, ranked by Signal.

Snowflake Inc.

$94.9M

AMERICAN INTERNATIONAL GROUP INC

$40.3M

Hinge Health, Inc.

$64.5M

TRAVELERS COMPANIES, INC.

$14.0M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.